December 13, 2013Clinical Cancer ResearchOpen Access

Mesothelin Overexpression Is a Marker of Tumor Aggressiveness and Is Associated with Reduced Recurrence-Free and Overall Survival in Early-Stage Lung Adenocarcinoma

View Full Paper

Ask AI

Bookmark

Abstract

MSLN expression in patients with early-stage lung ADC is associated with increased risk of recurrence and reduced OS, indicating that MSLN expression is a molecular marker of tumor aggressiveness and a potential target for therapy.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Kachala et al. (2013) studied this question.

synapsesocial.com/papers/69d74139ef4aa71f97f309fe https://doi.org/10.1158/1078-0432.ccr-13-1862

View Full Paper

Ask AI

Bookmark

Mesothelin Overexpression Is a Marker of Tumor Aggressiveness and Is Associated with Reduced Recurrence-Free and Overall Survival in Early-Stage Lung Adenocarcinoma

Abstract

Discussion

Cite This Study

Mesothelin Overexpression Is a Marker of Tumor Aggressiveness and Is Associated with Reduced Recurrence-Free and Overall Survival in Early-Stage Lung Adenocarcinoma

Abstract

Discussion

Cite This Study

Also Consider

Also Consider